Oncology & Cancer

MRI diagnostic for differentiating low-grade bladder cancers

(HealthDay)—Magnetic resonance (MR) imaging is accurate in differentiating T1 or lower tumors from T2 or higher tumors among patients with bladder cancer, according to a review published in the February issue of Radiology.

Oncology & Cancer

PET imaging detects fast-growing prostate cancer

A molecular imaging biomarker is able to detect fast-growing primary prostate cancer and distinguish it from benign prostate lesions, addressing an unmet clinical need. The new research, published in the July 2015 issue of ...

Oncology & Cancer

MRI-guided cryoablation viable for recurrent prostate cancer

(HealthDay)—In men with recurrent prostate cancer following radiation therapy, magnetic resonance imaging (MRI)-guided focal cryoablation is feasible and seems safe, according to a study published in the August issue of ...

Oncology & Cancer

SPECT/MR molecular imaging system makes its debut

The Society of Nuclear Medicine and Molecular Imaging's 2013 Annual Meetingmarks the unveiling of the successful application of a new preclinical hybrid molecular imaging system—single photon emission tomography and magnetic ...

Cardiology

Heart: Cardiac PET/MR measures up to PET/CT

Just a few years ago, integrated positron emission tomography and magnetic resonance (PET/MR) imaging was found only in research institutes, but little by little the technology has expanded into clinical practice. This is ...

page 1 from 2